BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33682578)

  • 1. Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
    Ali M; A R S; Al Hendy A
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):427-437. PubMed ID: 33682578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
    Simon JA; Al-Hendy A; Archer DF; Barnhart KT; Bradley LD; Carr BR; Dayspring T; Feinberg EC; Gillispie V; Hurtado S; Kim J; Liu R; Owens CD; Muneyyirci-Delale O; Wang A; Watts NB; Schlaff WD
    Obstet Gynecol; 2020 Jun; 135(6):1313-1326. PubMed ID: 32459423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids.
    Ali M; Raslan M; Ciebiera M; Zaręba K; Al-Hendy A
    Expert Opin Drug Saf; 2022 Apr; 21(4):477-486. PubMed ID: 34612122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study.
    Archer DF; Stewart EA; Jain RI; Feldman RA; Lukes AS; North JD; Soliman AM; Gao J; Ng JW; Chwalisz K
    Fertil Steril; 2017 Jul; 108(1):152-160.e4. PubMed ID: 28579415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Carr BR; Stewart EA; Archer DF; Al-Hendy A; Bradley L; Watts NB; Diamond MP; Gao J; Owens CD; Chwalisz K; Duan WR; Soliman AM; Dufek MB; Simon JA
    Obstet Gynecol; 2018 Nov; 132(5):1252-1264. PubMed ID: 30303923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of elagolix for treating uterine bleeding associated to uterine myomas.
    Barra F; Vitale SG; Seca M; Scala C; Leone Roberti Maggiore U; Cianci A; Ferrero S
    Expert Opin Pharmacother; 2020 Aug; 21(12):1419-1430. PubMed ID: 32401547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
    Ali M; Chen HY; Chiang YF; Badary OA; Hsia SM; Al-Hendy A
    Expert Opin Pharmacother; 2022 Mar; 23(4):421-429. PubMed ID: 35068291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
    Schlaff WD; Ackerman RT; Al-Hendy A; Archer DF; Barnhart KT; Bradley LD; Carr BR; Feinberg EC; Hurtado SM; Kim J; Liu R; Mabey RG; Owens CD; Poindexter A; Puscheck EE; Rodriguez-Ginorio H; Simon JA; Soliman AM; Stewart EA; Watts NB; Muneyyirci-Delale O
    N Engl J Med; 2020 Jan; 382(4):328-340. PubMed ID: 31971678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis.
    Muhammad J; Yusof Y; Ahmad I; Norhayati MN
    BMC Womens Health; 2022 Jan; 22(1):14. PubMed ID: 35033041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids.
    Lynch SE; Mayer DC
    Ann Pharmacother; 2022 Jan; 56(1):93-101. PubMed ID: 33998300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids.
    Stewart EA; Archer DF; Owens CD; Barnhart KT; Bradley LD; Feinberg EC; Gillispie-Bell V; Imudia AN; Liu R; Kim JH; Al-Hendy A
    J Womens Health (Larchmt); 2022 May; 31(5):698-705. PubMed ID: 34582715
    [No Abstract]   [Full Text] [Related]  

  • 12. Population Pharmacokinetics of Elagolix in Combination with Low-Dose Estradiol/Norethindrone Acetate in Women with Uterine Fibroids.
    Beck D; Winzenborg I; Liu M; Degner J; Mostafa NM; Noertersheuser P; Shebley M
    Clin Pharmacokinet; 2022 Apr; 61(4):577-587. PubMed ID: 34878624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.
    Syed YY
    Drugs; 2022 Oct; 82(15):1549-1556. PubMed ID: 36331779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of Elagolix/Estradiol/Norethindrone Acetate Fixed-Dose Combination Product: Phase 1 Results in Healthy Pre- and Postmenopausal Women.
    Chen MJ; Marroum P; Chiu YL; Neenan M; Mostafa NM; Shebley M
    Clin Pharmacol Drug Dev; 2024 Jun; 13(6):601-610. PubMed ID: 38593267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elagolix Suppresses Ovulation in a Dose-Dependent Manner: Results From a 3-Month, Randomized Study in Ovulatory Women.
    Archer DF; Ng J; Chwalisz K; Chiu YL; Feinberg EC; Miller CE; Feldman RA; Klein CE
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31650182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Clinical Drug-Drug Interactions of Elagolix, a Gonadotropin-Releasing Hormone Receptor Antagonist.
    Polepally AR; Ng JW; Salem AH; Dufek MB; Parikh A; Carter DC; Kamradt K; Mostafa NM; Shebley M
    J Clin Pharmacol; 2020 Dec; 60(12):1606-1616. PubMed ID: 33045114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elagolix, Estradiol, and Norethindrone Kit (Oriahnn) for the Management of Heavy Menstrual Bleeding Associated with Fibroids.
    Antoun J
    Am Fam Physician; 2021 Apr; 103(8):505-506. PubMed ID: 33856165
    [No Abstract]   [Full Text] [Related]  

  • 18. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas.
    Dababou S; Garzon S; Laganà AS; Ferrero S; Evangelisti G; Noventa M; D'Alterio MN; Palomba S; Uccella S; Franchi M; Barra F
    Expert Opin Investig Drugs; 2021 Sep; 30(9):903-911. PubMed ID: 34278887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oriahnn for fibroid-associated heavy menstrual bleeding.
    Med Lett Drugs Ther; 2021 Apr; 63(1621):51-52. PubMed ID: 33830967
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
    Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; Critchley HOD; Li Y; McKain L; Arjona Ferreira JC; Langenberg AGM; Wagman RB; Stewart EA
    N Engl J Med; 2021 Feb; 384(7):630-642. PubMed ID: 33596357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.